Breaking News Bar

Business News and Information

Three Most Active Canadian Stocks: $HRH $THRM $RVV

*If You Own HRH, THRM, RVV Then Click Here to Join Our Community Of Traders

The Market Signal was created as a platform to help investors, if you own (TSX:HRH), (TSX:THRM) or (TSX:RVV) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.
(Click link above or copy, paste and hit enter in your browser for your report)

Hillcrest Petroleum Raised $1,022,100 As Gross Proceeds Through Private Placement

(Click link above or copy, paste and hit enter in your browser for your report)

Hillcrest Petroleum Ltd (TSX: HRH) surged 85.71% on a traded volume of 17.32 million shares. The Canadian oil and gas producer, on August 4 raised an amount $1,022,100 as gross proceeds through non-brokered private placement. This is done so as to fund its oil asset based in West Hazel in Saskatchewan.

Some amount of this proceed is to be used for retiring a few payables associated with Saskatchewan's gas and oil assets of the issuer. Apart from this, the company will use the proceeds for general working capital operations.

Therma Bright Partners With Orpheus Medica To Develop A Rapid Covid-19 Testing Kit

(Click link above or copy, paste and hit enter in your browser for your report)

The progressive medical device technology company, Therma Bright Inc (TSX: THRM) is moving north with 18.92% gain on 12.40 traded volume. Therma has recently signed a letter of intent with another company, Orpheus Medica Inc. The agreement is signed so as to develop a rapid COVID-19 testing kit. This rapid saliva testing detection test will provide quicker results for SARS-CoV-2 virus detection.

For this purpose, Therma will bring to the table, funding for the project in different phases. Therma shall also be facilitating medical device expertise for pacing up development of this screening test.

Revive Therapeutics Receives FDA Nod For Phase 3 Clinical Trial For Bucillamine Treatment

(Click link above or copy, paste and hit enter in your browser for your report)

The volume traded of Revive Therapeutics Ltd (TSX: RVV) was 10.84 million shares on Aug 4. Revive is seen as a key COVID player as its Phase 3 clinical trial for a treatment called Bucillamine. The company has received regulatory approval from the U.S. FDA recently.

This Phase 3 study is called A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Bucillamine in Patients with Mild-Moderate COVID-19. In the study, the company will sign up 1,000 patients, randomized as 1:1:1. These patients shall be administered treatment Bucillamine 100 mg, Bucillamine 200 mg, or placebo- all, thrice a day for up to 14 days. This is considered as the period of isolation in COVID-19 treatment.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.


The post Three Most Active Canadian Stocks: $HRH $THRM $RVV appeared first on The Market Signals.

comtex tracking


Is there a problem with this press release? Contact the source provider Comtex at

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear